Patents by Inventor Alexei Goraltchouk
Alexei Goraltchouk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12226613Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: GrantFiled: December 8, 2022Date of Patent: February 18, 2025Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Bryan C. Grygus, Alfred Marino, Rachel P. Arnott, Scott Barton, Bart E. Burgess, Richard Gildersleeve, Alexei Goraltchouk, Daniel Halbig, Christopher Kanel, Trevor Langley
-
Publication number: 20230105585Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: ApplicationFiled: December 8, 2022Publication date: April 6, 2023Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Bryan C. GRYGUS, Alfred MARINO, Rachel P. ARNOTT, Scott BARTON, Bart E. BURGESS, Richard GILDERSLEEVE, Alexei GORALTCHOUK, Daniel HALBIG, Christopher KANEL, Trevor LANGLEY
-
Publication number: 20230020306Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, wherein the cap may include a central longitudinal axis, a first end having a first cross-sectional dimension, and a second end having a second cross-sectional dimension larger than the first cross-sectional dimension.Type: ApplicationFiled: September 23, 2022Publication date: January 19, 2023Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Courtney NICHOLAS, Scott BARTON, Bart E. BURGESS, Alexei GORALTCHOUK
-
Patent number: 11547801Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: GrantFiled: May 4, 2018Date of Patent: January 10, 2023Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Bryan C. Grygus, Alfred Marino, Rachel P. Arnott, Scott Barton, Bart E. Burgess, Richard Gildersleeve, Alexei Goraltchouk, Daniel Halbig, Christopher Kanel, Trevor Langley
-
Publication number: 20220401302Abstract: The present disclosure provides aseptic vial piercing and sterilization systems, and methods of assembling, using and sterilizing same. The systems and methods utilize a pre-sterilized primary container including a first end, a first cavity, a second end with an opening in communication with the first cavity, a septum at least partially sealing the opening, and a product within the first cavity. The systems and methods include an injection assembly including a first end portion of a hollow flowpath forming member. The injection assembly and the primary container may be assembled in a non-sterile environment to form a second cavity extending about the first end portion of the flowpath forming member and to the primary container. The second cavity may then be selectively sterilized in a non-deleterious manner to the product to allow the first end portion to aseptically pierce the septum to extend into the first cavity.Type: ApplicationFiled: June 29, 2022Publication date: December 22, 2022Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Rachel Paige ARNOTT, Bart E. BURGESS, Michael CUPICHA, Alexei GORALTCHOUK, Bryan GRYGUS, Mike STELMAH
-
Patent number: 11484654Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, which may include a curved sidewall extending radially outward. The curved sidewall may include a protrusion.Type: GrantFiled: June 29, 2018Date of Patent: November 1, 2022Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart E. Burgess, Alexei Goraltchouk
-
Patent number: 11406565Abstract: The present disclosure provides aseptic vial piercing and sterilization systems, and methods of assembling, using and sterilizing same. The systems and methods utilize a pre-sterilized primary container including a first end, a first cavity, a second end with an opening in communication with the first cavity, a septum at least partially sealing the opening, and a product within the first cavity. The systems and methods include an injection assembly including a first end portion of a hollow flowpath forming member. The injection assembly and the primary container may be assembled in a non-sterile environment to form a second cavity extending about the first end portion of the flowpath forming member and to the primary container. The second cavity may then be selectively sterilized in a non-deleterious manner to the product to allow the first end portion to aseptically pierce the septum to extend into the first cavity.Type: GrantFiled: December 6, 2018Date of Patent: August 9, 2022Assignee: Regeneran Pharmaceuticals, Inc.Inventors: Rachel Paige Arnott, Bart E. Burgess, Michael Cupicha, Alexei Goraltchouk, Bryan Grygus, Mike Stelmah
-
Patent number: 10869966Abstract: A syringe system, piston seal systems, stopper systems, and methods for assembling and using the syringe systems. The piston seal system including a piston seal member and a piston head member. The injection system including a container, a piston seal system positioned within the container, and a stopper system coupled to an end of the container. The method of assembling an injection system, the method includes obtaining a container, a piston seal system, and a stopper system. The method also includes inserting the piston seal system into a cavity within the container. The method further includes securing the stopper system at an end of the container in an opening of the cavity. Methods of using the syringe system, piston seal systems, and stopper systems are also disclosed.Type: GrantFiled: February 19, 2016Date of Patent: December 22, 2020Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Michael Cupicha, Alexei Goraltchouk, Ian Hart, Mike Stelmah
-
Publication number: 20200139050Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, which may include a curved sidewall extending radially outward. The curved sidewall may include a protrusion.Type: ApplicationFiled: June 29, 2018Publication date: May 7, 2020Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Courtney NICHOLAS, Scott BARTON, Bart E. BURGESS, Alexei GORALTCHOUK
-
Publication number: 20200038550Abstract: The present specification discloses porous materials, methods of forming such porous materials, biocompatible implantable devices that include such porous materials, and methods of making such biocompatible implantable devices.Type: ApplicationFiled: July 19, 2019Publication date: February 6, 2020Inventors: Futian Liu, Nicholas J. Manesis, Alexei Goraltchouk, Dimitri Stroumpoulis
-
Patent number: D892311Type: GrantFiled: April 25, 2018Date of Patent: August 4, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Alex Zuyev, Alexei Goraltchouk, Bart Burgess
-
Patent number: D892312Type: GrantFiled: April 25, 2018Date of Patent: August 4, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk
-
Patent number: D898191Type: GrantFiled: April 25, 2018Date of Patent: October 6, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk
-
Patent number: D901008Type: GrantFiled: April 25, 2018Date of Patent: November 3, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk, Alex Zuyev
-
Patent number: D903856Type: GrantFiled: June 29, 2018Date of Patent: December 1, 2020Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk, Alex Zuyev
-
Patent number: D908867Type: GrantFiled: April 25, 2018Date of Patent: January 26, 2021Assignees: Sanofi-Aventis Deutschland GMBH, Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk
-
Patent number: D916277Type: GrantFiled: July 23, 2020Date of Patent: April 13, 2021Assignees: Sanofi-Aventis Deutschland GMBH, Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Alex Zuyev, Bart Burgess, Alexei Goraltchouk
-
Patent number: D932006Type: GrantFiled: November 21, 2018Date of Patent: September 28, 2021Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart E. Burgess, Alexei Goraltchouk, Paige Waechter, Alex Zuyev
-
Patent number: D934413Type: GrantFiled: July 23, 2020Date of Patent: October 26, 2021Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk
-
Patent number: D958973Type: GrantFiled: July 26, 2021Date of Patent: July 26, 2022Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart E. Burgess, Alexei Goraltchouk, Paige Waechter